| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue | 182 | 522 | 685 | | Cost of Revenue | 112 | 56 | 29 | | | Gross Profit | 70 | 466 | 656 | | | Operating Expenses | | Research Development | 11,289 | 15,249 | 11,443 | | Selling General and Administrative | 4,950 | 6,436 | 8,682 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (16,169) | (21,219) | (19,469) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 296 | 1,170 | 1,875 | | Earnings Before Interest And Taxes | (15,873) | (20,049) | (17,594) | | Interest Expense | 73 | 84 |
-
| | Income Before Tax | (15,946) | (20,133) | (17,594) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,946) | (20,133) | (17,594) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,946) | (20,133) | (17,594) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,946) | ($20,133) | ($17,594) |
|
0.29% Nasdaq 
0.00 (1.13%) 
Income Statement
